Akari Therapeutics (AKTX) Operating Income Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -347.04% |
| Dec 31, 2025 | 97.12% |
| Sep 30, 2025 | -152.96% |
| Jun 30, 2025 | 58.13% |
| Mar 31, 2025 | 41.14% |
| Dec 31, 2024 | -2,100.12% |
| Sep 30, 2024 | -16.75% |
| Jun 30, 2024 | -61.41% |
| Mar 31, 2024 | -30.37% |
| Jun 30, 2023 | 20.65% |
| Mar 31, 2023 | 12.39% |
| Jun 30, 2022 | -34.32% |
| Mar 31, 2022 | 5.49% |
| Dec 31, 2021 | -296,653.45% |
| Sep 30, 2021 | -492.75% |
| Jun 30, 2021 | 26.75% |
| Mar 31, 2021 | -12.62% |
| Dec 31, 2020 | 11.89% |
| Sep 30, 2020 | 92.08% |
| Jun 30, 2020 | 1.99% |
| Mar 31, 2020 | -41,288.55% |
| Dec 31, 2019 | -65.37% |
| Sep 30, 2019 | -4.40% |
| Jun 30, 2019 | 24.41% |
| Mar 31, 2019 | 100.28% |
| Dec 31, 2018 | 65.23% |
| Sep 30, 2018 | 65.04% |
| Jun 30, 2018 | -8.57% |
| Mar 31, 2018 | 48.02% |
| Dec 31, 2017 | -38.13% |
| Sep 30, 2017 | -41.85% |
| Jun 30, 2017 | 2.27% |
| Mar 31, 2017 | -115.04% |
| Dec 31, 2016 | -129.63% |
| Sep 30, 2016 | 74.19% |
| Jun 30, 2016 | -473.16% |
| Mar 31, 2016 | -132.80% |
| Dec 31, 2015 | -288.27% |
| Sep 30, 2015 | -10,599.03% |
| Jun 30, 2015 | 43.69% |
| Mar 31, 2015 | 12.13% |